Hani Hassoun, MD

Hani Hassoun, MD

I am a board-certified hematologist/oncologist with a special interest in plasma cell dyscrasias — a group of disorders that includes multiple myeloma, amyloidosis, light chain deposition disease, POEMS syndrome, and Waldenström’s macroglobulinemia. There have been tremendous advances in this field over the past decade, and several new drugs are available or in development to manage these conditions. With my colleagues at Memorial Sloan Kettering Cancer Center, I have focused on developing and optimizing new approaches to treat these diseases, including both new drugs and new strategies to improve patients’ outcomes.

In multiple myeloma we currently have several clinical trials that are addressing important questions in patients who are newly diagnosed and have never been treated to better define the role and timing of autologous stem cell transplantation. We are also conducting several clinical trials in patients whose disease has recurred after initial treatment in order to develop new drugs that would be effective against the disease.

Appointments for New Patients
Clinical Expertise

Plasma Cell Dyscrasias: Multiple Myeloma; Amyloidosis; Light Chain deposition disease; Coagulation Disorders in Cancer Patients

Languages Spoken

MD, University of Pierre et Marie Curie (Paris, France)


Brigham and Women’s Hospital/Harvard Medical School


St. Elizabeth’s Medical Center/Tufts Medical School

Board Certifications

Internal Medicine; Hematology/Medical Oncology

Publications by Hani Hassoun
Visit PubMed for full listing of Hani Hassoun journal articles
Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.